What if you could help change melanoma research and outcomes for the better?
In order to save lives, we have to strategically improve melanoma research. Breast cancer did it. Prostate cancer did it. Melanoma can do it now with the opening of a national primary tissue bank. It is the key to the cure. Watch our video to learn more.
Recurrences of early stage (stage II) melanoma are more often detected by patients and their physicians than by routine imaging tests, according to study results published online on the Journal of... […]
Clinical trials of a new immunotherapy, pembrolizumab, have shown that it prolongs life significantly for patients with bladder cancer and is active against a rare sub-type of melanoma, called... […]
By 2050 the death rates from malignant melanoma will have decreased from their current levels but the numbers of people dying from the disease will have increased due to the aging of populations. […]
Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. […]
Find out how you can help.